<span style="color: #222222;">The clinical&nbsp;trial&nbsp;of Bharat Biotech's COVAXIN on children began at AIIMS Patna. All 15 kids who voluntarily turned up for the vaccine&nbsp;trial. All the volunteers had gone through the screening process such as RT-PCR, antibody test and general check up prior to receiving their shots.</span><br />” <span style="color: #222222;">&nbsp;</span><br />” <span style="color: #222222;">Three children were found fit for vaccine&nbsp;trials&nbsp;after screening. Children found with antibodies could not participate in the vaccine trial. Dr Sanjeev Kumar, nodal-in-charge for COVID at AIIMS, Patna&nbsp;said, the&nbsp;children who received their first shot are in the age group of 12 to 18 years. After being administered&nbsp;<a href="http://0.5.ml/" target="_blank"><span style="color: #1155cc;">0.5.ml</span></a>&nbsp;dose of intramuscular injection, the children were monitored for two hours.&nbsp;</span><br />” <br />” <span style="color: #222222;">The second dose will be given after four weeks. During this period their health will be closely monitored.</span><br />” &nbsp;<br />